{
  "docId": "019de517-740e-746d-9716-4a0728bc32aa",
  "docSlug": "64e4d5ca4b0f77867c88fcf9cc9649c0",
  "documentTitle": "NVIDIA | Investor Presentation Deck | 65 slides",
  "authorId": "nvidia",
  "authorName": "NVIDIA",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 65,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "propose_solution",
  "function": "propose_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de517-740e-746d-9716-4a0728bc32aa/22",
  "deckHref": "/decks/019de517-740e-746d-9716-4a0728bc32aa",
  "deckJsonHref": "/decks/019de517-740e-746d-9716-4a0728bc32aa.json",
  "deckAnchorHref": "/decks/019de517-740e-746d-9716-4a0728bc32aa#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.61,
        "w": 0.42,
        "x": 0.54,
        "y": 0.15
      },
      "kind": "image",
      "text": null,
      "attrs": {},
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "20391c28-6730-4a25-8f14-34dc050e1869",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.47,
        "w": 0.409,
        "x": 0.076,
        "y": 0.336
      },
      "kind": "list",
      "text": "Genentech is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently\nNVIDIA will work with Genentech to accelerate Genentech's proprietary algorithms on NVIDIA DGX Cloud\nGenentech plans to use NVIDIA BioNeMo to help accelerate and optimize their AI drug discovery platform\nNVIDIA plans to use insights learned from this collaboration to improve its BioNeMo platform\nBioNeMo is now generally available as a training service",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "531706d2-28ed-4158-9eed-05427d709397",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.156,
        "w": 0.409,
        "x": 0.076,
        "y": 0.074
      },
      "kind": "title",
      "text": "NVIDIA Collaborates With Genentech to Accelerate Drug Discovery Using Generative AI",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "74e96f43-61cf-4b13-bf98-e9b8561d8f9a",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 63,
      "from": 6,
      "beatId": "1b4d46fc-6d6e-448a-a6a6-a1dd2c5e67c9",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Financials",
      "beatSlug": "sequoia-pitch-financials",
      "evidence": "NVIDIA's financial performance and growth strategy",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}